Zinc Supplementation and Cardiovascular Risk in HIV

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 16, 2018

Study Completion Date

April 16, 2018

Conditions

HIVInflammation

Interventions

DIETARY_SUPPLEMENT

Zinc gluconate

Participants will take a daily dose of zinc gluconate.

Trial Locations (1)

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Grace McComsey

OTHER

NCT02856269 - Zinc Supplementation and Cardiovascular Risk in HIV | Biotech Hunter | Biotech Hunter